Paracetamol Accord (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the synthesis of prostaglandins that mediate pain and temperature regulation. This central action lowers neuronal excitability, producing analgesic and antipyretic effects while having minimal peripheral anti‑inflammatory activity.

The specific dose of Paracetamol Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. Healthcare professionals follow local guidelines and adjust the regimen to achieve the desired analgesic or antipyretic effect while minimizing risk.

Safety data for intravenous paracetamol in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should evaluate the potential benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the Paracetamol Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), intravenous paracetamol offers analgesic and antipyretic benefits without the gastrointestinal or platelet‑inhibiting effects typical of NSAIDs. It is also faster acting than oral formulations, making it suitable for acute settings where rapid onset is desired.

Paracetamol Accord should be stored at ambient temperature, preferably below 25 °C. Keep the solution in its original packaging, protect it from direct light and moisture, and avoid freezing. Inspect the container for any signs of particulate matter or discoloration before use.

Paracetamol Accord is administered intravenously by a qualified healthcare professional. The solution is typically diluted in a compatible IV fluid and infused over a short period, following the dosage instructions provided by the prescriber and adhering to aseptic technique.

The most serious risks include severe allergic reactions such as anaphylaxis, rare but life‑threatening skin conditions like Stevens‑Johnson syndrome, and hepatotoxicity, especially when dosing exceeds recommended limits or in patients with pre‑existing liver disease.

Paracetamol Accord should be avoided in patients with known hypersensitivity to paracetamol or any component of the formulation, in those with severe hepatic impairment, and in individuals who have taken excessive amounts of other paracetamol‑containing products. Clinicians should also exercise caution in patients with significant renal dysfunction.